108 related articles for article (PubMed ID: 37313906)
1. Raised carbohydrate antigen 19-9 levels detect recurrences and impacts overall and disease-free survival in radically resected gallbladder cancer: A simple surveillance marker?
Agrawal S; Saxena R
J Cancer Res Ther; 2023; 19(2):273-277. PubMed ID: 37313906
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of the Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis.
Mochizuki T; Abe T; Amano H; Hanada K; Hattori M; Kobayashi T; Nakahara M; Ohdan H; Noriyuki T
Ann Surg Oncol; 2018 Jun; 25(6):1699-1708. PubMed ID: 29626304
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival.
Bedmutha AS; Agrawal A; Rangarajan V; Goel M; Patkar S; Puranik AD; Ramadwar M; Purandare NC; Shah S; Choudhury S
Jpn J Radiol; 2023 Feb; 41(2):201-208. PubMed ID: 36121626
[TBL] [Abstract][Full Text] [Related]
4. Does CA 19-9 Have Prognostic Relevance in Gallbladder Carcinoma (GBC)?
Agrawal S; Lawrence A; Saxena R
J Gastrointest Cancer; 2018 Jun; 49(2):144-149. PubMed ID: 28105553
[TBL] [Abstract][Full Text] [Related]
5. Carcinoembryonic antigen directed PET-CECT scanning for postoperative surveillance of colorectal cancer.
Vallam KC; Guruchannabasavaiah B; Agrawal A; Rangarajan V; Ostwal V; Engineer R; Saklani A
Colorectal Dis; 2017 Oct; 19(10):907-911. PubMed ID: 28444968
[TBL] [Abstract][Full Text] [Related]
6. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
7. Nomogram to predict overall survival after gallbladder cancer resection in China.
Bai Y; Liu ZS; Xiong JP; Xu WY; Lin JZ; Long JY; Miao F; Huang HC; Wan XS; Zhao HT
World J Gastroenterol; 2018 Dec; 24(45):5167-5178. PubMed ID: 30568393
[TBL] [Abstract][Full Text] [Related]
8. Role of Adjuvant Treatment in High-risk Patients Following Resection for Gallbladder Cancer.
Park Y; Kim K; Park HJ; Chun HJ; Choi D; Kim K
In Vivo; 2022; 36(2):961-968. PubMed ID: 35241556
[TBL] [Abstract][Full Text] [Related]
9. Utility of (18) F-FDG PET/CT and CECT in conjunction with serum CA 19-9 for detecting recurrent pancreatic adenocarcinoma.
Rayamajhi S; Balachandran A; Katz M; Reddy A; Rohren E; Bhosale P
Abdom Radiol (NY); 2018 Feb; 43(2):505-513. PubMed ID: 28900703
[TBL] [Abstract][Full Text] [Related]
10. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy.
Lee JW; Kim YT; Lee SH; Son JH; Kang JW; Ryu JK; Jang DK; Paik WH; Lee BS
Gut Liver; 2018 Jan; 12(1):102-110. PubMed ID: 29069888
[TBL] [Abstract][Full Text] [Related]
11. Consolidation chemoradiation (cCTRT) improves survival in responders to first-line chemotherapy (CT) in locally advanced gallbladder cancer (LA-GBC): A new standard of care?
Alam MN; Agrawal S; Rastogi N; Maria Das KJ
Indian J Cancer; 2022; 59(4):577-583. PubMed ID: 36861528
[TBL] [Abstract][Full Text] [Related]
12. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Prognostic Markers {CEA, Ca19.9, Neutrophil To Lymphocyte Ratio (NLR) and Platelet to Lymphocyte Ratio (PLR)} With Progression Free Survival (PFS) in Advanced/Metastatic Gallbladder Carcinoma.
Naik MD; Kataria SP; Kumar G; Singh R
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443542
[TBL] [Abstract][Full Text] [Related]
14. Early Recurrence in Resected Gallbladder Carcinoma: Clinical Impact and Its Preoperative Predictive Score.
Shimizu Y; Ashida R; Sugiura T; Okamura Y; Ohgi K; Yamada M; Otsuka S; Aramaki T; Notsu A; Uesaka K
Ann Surg Oncol; 2022 Sep; 29(9):5447-5457. PubMed ID: 35666409
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine-cisplatin (GC) as adjuvant chemotherapy in resected stage II and stage III gallbladder cancers (GBC): a potential way forward.
Ostwal V; Swami R; Patkar S; Majumdar S; Goel M; Mehta S; Engineer R; Mandavkar S; Kumar S; Ramaswamy A
Med Oncol; 2018 Mar; 35(4):57. PubMed ID: 29564657
[TBL] [Abstract][Full Text] [Related]
16. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
[TBL] [Abstract][Full Text] [Related]
17. Can postoperative surveillance with serial CEA immunoscintigraphy detect resectable rectal cancer recurrence and potentially improve tumor-free survival?
Lechner P; Lind P; Goldenberg DM
J Am Coll Surg; 2000 Nov; 191(5):511-8. PubMed ID: 11085731
[TBL] [Abstract][Full Text] [Related]
18. Patterns of failure and determinants of outcomes following radical re-resection for incidental gallbladder cancer.
Barreto SG; Pawar S; Shah S; Talole S; Goel M; Shrikhande SV
World J Surg; 2014 Feb; 38(2):484-9. PubMed ID: 24196171
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of adjuvant chemoradiation and predictors of survival after extended cholecystectomy in gall bladder carcinoma: a single institution experience from an endemic region.
Agrawal S; Gupta PK; Rastogi N; Lawrence A; Kumari N; Das KJ; Saxena R
J Gastrointest Cancer; 2015 Mar; 46(1):48-53. PubMed ID: 25511013
[TBL] [Abstract][Full Text] [Related]
20. Multimodality management of gallbladder cancer can lead to a better outcome: Experience from a tertiary care oncology centre in North India.
Goel S; Aggarwal A; Iqbal A; Talwar V; Mitra S; Singh S
World J Gastroenterol; 2021 Dec; 27(45):7813-7830. PubMed ID: 34963744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
